Moderna

Moderna’s chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new vaccines. 

The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.

Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.

Moderna said Tuesday it had asked the Food and Drug Administration to authorize an updated version of its Covid booster shot.

The Biden administration says it has reached an agreement with Moderna to buy 66 million doses of the company’s next generation of COVID-19 vaccine targeting the highly transmissible omicron variant.

Alyssa Allen and her family of four have waited patiently for this moment. The FDA began to green-light the COVID-19 vaccine for infants, toddlers and children five and under. Allen’s daughter Hallie is 3 years old, the only one in the family not protected. “The big word is ‘finally,’ my family has been waiting what feels like forever to get…

NBC 6’s Marissa Bagg has details on the FDA panel vote authorizing vaccines for kids under 5 and the next step that follows

The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17. A vaccine made by Pfizer has been available since last year for those ages. The Food and Drug...

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect children under the age of 6.

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.

A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.

Many Americans can now get a second COVID-19 booster, but it’s hard to tell who really needs another shot right now and who could wait.

Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers

The request comes two days after Pfizer asked the Food and Drug Administration to authorize a second booster shot for adults 65 and older.

Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults

Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness

Nearly 60 participants were given their first doses of the experimental HIV vaccine Thursday

Moderna is testing an omicron-specific COVID-19 vaccine booster.